Cargando…
Recognition of allergic conjunctivitis in patients with allergic rhinitis
AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening que...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646537/ https://www.ncbi.nlm.nih.gov/pubmed/23663473 http://dx.doi.org/10.1186/1939-4551-6-4 |
_version_ | 1782268609039433728 |
---|---|
author | Williams, Daniel C Edney, Gabrielle Maiden, Bianca Smith, Peter K |
author_facet | Williams, Daniel C Edney, Gabrielle Maiden, Bianca Smith, Peter K |
author_sort | Williams, Daniel C |
collection | PubMed |
description | AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify “silent” disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms. RESULTS: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine. CONCLUSIONS: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC. |
format | Online Article Text |
id | pubmed-3646537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-36465372013-05-08 Recognition of allergic conjunctivitis in patients with allergic rhinitis Williams, Daniel C Edney, Gabrielle Maiden, Bianca Smith, Peter K World Allergy Organ J Original Research AIMS: To identify the incidence of allergic conjunctivitis in patients with allergic rhinitis. METHODS: One hundred and eighty seven consecutive patients with allergic rhinitis (AR) were directly questioned if they have allergic conjunctivitis (AC) and this was clarified using standard screening questions relating to red, itchy and watery eyes recorded through a total ocular symptom score (TOSS). Patients were also asked about further symptoms that may be attributable to AC: eyelid dermatitis, frequent blinking; eye sensitivity and frontal headache from squinting or. blinking. All patients were given a drop of olopatadine hydrochloride 0.1% in each eye to help identify “silent” disease. 20 healthy non-atopic controls were also treated with olopatadine drops and questioned on ocular symptoms. RESULTS: Fifty five percent of patients with AR were identified as having AC by direct questioning and the use of the TOSS questionaire. A further 41% were identifiable by asking additional questions and performing therapeutic challenge with olopadatine. CONCLUSIONS: AC is a frequent comorbid condition occurring in 95% of our patients with AR. Only 55% of patients were able to identify that they had AC based on standard screening questions. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC. World Allergy Organization 2013-02-12 /pmc/articles/PMC3646537/ /pubmed/23663473 http://dx.doi.org/10.1186/1939-4551-6-4 Text en Copyright ©2013 Williams et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Williams, Daniel C Edney, Gabrielle Maiden, Bianca Smith, Peter K Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title | Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title_full | Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title_fullStr | Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title_full_unstemmed | Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title_short | Recognition of allergic conjunctivitis in patients with allergic rhinitis |
title_sort | recognition of allergic conjunctivitis in patients with allergic rhinitis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646537/ https://www.ncbi.nlm.nih.gov/pubmed/23663473 http://dx.doi.org/10.1186/1939-4551-6-4 |
work_keys_str_mv | AT williamsdanielc recognitionofallergicconjunctivitisinpatientswithallergicrhinitis AT edneygabrielle recognitionofallergicconjunctivitisinpatientswithallergicrhinitis AT maidenbianca recognitionofallergicconjunctivitisinpatientswithallergicrhinitis AT smithpeterk recognitionofallergicconjunctivitisinpatientswithallergicrhinitis |